UnitedHealth Group Shares Jump 7.3% on Neutral Reddit Sentiment

UNHUNH

UnitedHealth shares rose 7.3% over the past week as sentiment swung from a bearish 18 in November to a neutral 42 today, after peaking at 82 in December. Trading near its 50-day and 200-day averages, the stock has institutional validation from Berkshire Hathaway’s 5 million share position.

1. Retail Sentiment Rebound Drives Stock Recovery

Over the past week, UnitedHealth Group shares climbed by 7.3% as retail investor sentiment on key social platforms shifted markedly from extreme bearishness to a neutral stance. In November, the company’s social sentiment score on Reddit’s flagship forums registered at just 18 out of 100, plunged further following the December 2024 shooting of CEO Brian Thompson, then surged to a bullish peak of 82 in late December before settling at a more balanced 42 by mid‐January. This 40‐point improvement from late September reflects a stabilization of online discourse and coincides with institutional support, including a disclosed 5 million share position by Berkshire Hathaway. Options traders have also shown renewed conviction, with reports of deep in‐the‐money call positions and discussions of LEAPS strategies suggesting growing confidence in UnitedHealth’s longer‐term outlook.

2. FTC Pauses OptumRx Proceedings, Settlement Talks Underway

On January 20, the Federal Trade Commission formally stayed its administrative case against UnitedHealth Group’s OptumRx unit, along with CVS Caremark and Cigna’s Express Scripts, granting a 14‐day suspension of all discovery, briefing, and decision deadlines and postponing the evidentiary hearing until July 1. The September 2024 complaint alleges that pharmacy benefit managers used rebate structures and market dominance to inflate insulin list prices. The pause in enforcement, combined with renewed political scrutiny—including a recent executive order targeting PBM “kickbacks”—signals that regulators and defendants may be exploring a negotiated settlement to resolve accusations of anti‐competitive conduct.

3. CEO Testimony Highlights Profit Rebates and Cost Restraint Efforts

During testimony before two House panels, UnitedHealth Group CEO Stephen Hemsley emphasized that rising hospital and drug prices, rather than insurer margins, are the primary drivers of U.S. health care spending growth. Hemsley pledged to eliminate and rebate profits on Affordable Care Act exchange coverage for the current year, promising greater transparency around revenue from those plans. He cited nearly $300 billion in negotiated provider discounts and $35 billion saved through fraud and waste reduction initiatives last year. Hemsley also unveiled a Rural Payment Acceleration Pilot aimed at halving payment collection times for independent rural hospitals in states such as Oklahoma and Minnesota, underscoring UnitedHealth’s focus on value‐based care models to improve affordability and access.

Sources

B2ZZB
+1 more